Literature DB >> 1745407

Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies.

L A Hansen1, E Masliah, S Quijada-Fawcett, D Rexin.   

Abstract

Entorhinal cortex is the major source of hippocampal afferents. Its neurons, especially in layer 2, develop neurofibrillary tangles (NFTs) in Alzheimer disease (AD). We quantified entorhinal NFTs in cases of AD, elderly controls, and in brains with both AD pathology and subcortical and neocortical Lewy bodies, (a Lewy body variant, LBV). A nosologic controversy hinges on whether LBVs are a form of AD or a different disease, since they have few neocortical NFTs and their neuritic plaques often lack paired helical filament immunoreactivity. The LBVs had more entorhinal NFTs than controls (P less than 0.001), but fewer than ADs (P less than 0.02), despite comparable numbers of neuritic plaques. AD pathology in LBVs is of moderate severity, or perhaps in an earlier developmental stage.

Entities:  

Mesh:

Year:  1991        PMID: 1745407     DOI: 10.1016/0304-3940(91)90478-c

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Reduced hypocretin (orexin) levels in dementia with Lewy bodies.

Authors:  Stephanie Lessig; Kiren Ubhi; Douglas Galasko; Anthony Adame; Emiley Pham; Kelly Remidios; Michael Chang; Lawrence A Hansen; Eliezer Masliah
Journal:  Neuroreport       Date:  2010-08-04       Impact factor: 1.837

2.  Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD.

Authors:  Brian Spencer; Sarah Michael; Jay Shen; Kori Kosberg; Edward Rockenstein; Christina Patrick; Anthony Adame; Eliezer Masliah
Journal:  Mol Ther       Date:  2012-04-17       Impact factor: 11.454

3.  Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease.

Authors:  David P Salmon; William C Heindel; Joanne M Hamilton; J Vincent Filoteo; Varun Cidambi; Lawrence A Hansen; Eliezer Masliah; Douglas Galasko
Journal:  Neuropsychologia       Date:  2015-07-14       Impact factor: 3.139

4.  Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease.

Authors:  Kiren Ubhi; Kevin Peng; Stephanie Lessig; Jennilyn Estrella; Anthony Adame; Douglas Galasko; David P Salmon; Lawrence A Hansen; Claudia H Kawas; Eliezer Masliah
Journal:  Neurosci Lett       Date:  2010-09-21       Impact factor: 3.046

5.  Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.

Authors:  Vicente Sancenon; Sue-Ann Lee; Christina Patrick; Janice Griffith; Amy Paulino; Tiago F Outeiro; Fulvio Reggiori; Eliezer Masliah; Paul J Muchowski
Journal:  Hum Mol Genet       Date:  2012-02-21       Impact factor: 6.150

6.  Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.

Authors:  Leslie Crews; Brian Spencer; Paula Desplats; Christina Patrick; Amy Paulino; Edward Rockenstein; Lawrence Hansen; Anthony Adame; Douglas Galasko; Eliezer Masliah
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

7.  Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32.

Authors:  K Wakabayashi; L A Hansen; E Masliah
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.